China Biologic Products Price Prediction
As of today the value of rsi of China Biologic's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
Oversold Vs Overbought
0
Oversold | Overbought |
China Biologic Products stock price prediction is an act of determining the future value of China Biologic shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of China Biologic's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of China Biologic and does not consider all of the tangible or intangible factors available from China Biologic's fundamental data. We analyze noise-free headlines and recent hype associated with China Biologic Products, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of China Biologic based on different types of headlines from major news networks to social media. The China stock price prediction module provides an analysis of price elasticity to changes in media outlook on China Biologic over a specific investment horizon. Using China Biologic hype-based prediction, you can estimate the value of China Biologic Products from the perspective of China Biologic response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in China Biologic. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in China Biologic to buy its stock at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
China Biologic after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
China |
Symbol | CBPO |
Name | China Biologic Products |
Type | Stock |
Country | United States |
Exchange | NASDAQ |
Hype Analysis is not found for China Biologic Products at this timeWe are unable to locate China Biologic Products hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
CB | Chubb | Company |
CBADX | Columbia Total Return | Mutual Fund |
CBH | AllianzGI Convertible Income | ETF |
CBT | CBT | Cryptocurrency |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
All Next | Launch Module |
China Biologic Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Story Coverage note for China Biologic
The number of cover stories for China Biologic depends on current market conditions and China Biologic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China Biologic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China Biologic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
China Biologic Short Properties
China Biologic's future price predictability will typically decrease when China Biologic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China Biologic Products often depends not only on the future outlook of the potential China Biologic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China Biologic's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out | 2.01% | |
Short Percent Of Float | 3.45% | |
Float Shares | 13.05M | |
Shares Short Prior Month | 904.69k | |
Average Daily Volume Last 10 Day | 87.12k | |
Average Daily Volume In Three Month | 156.75k | |
Date Short Interest | 31st of March 2021 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world |